|
CME: Case 29-2009: An 81-Year-Old Man with Weight Loss, Odynophagia, and Failure to Thrive
Mercredi 16 Septembre 2009 - 08:56 - 6 mois depuis - Santé - New England Journal of Medicin (No abstract is available for this citation) |
|
Joseph Stiglitz et ses confrères sont passés à côté de la vraie question
Mercredi 16 Septembre 2009 - 07:58 - 6 mois depuis - Santé - Le monde sciences Début 2008, Nicolas Sarkozy avait mis en place la Commission sur la mesure de la performance économique et du progrès social. |
|
Particle-Beam Therapy Holds Promise but Safety Evidence is Lacking
Mercredi 16 Septembre 2009 - 06:50 - 6 mois depuis - Cancérologie - Medscape cancérologie Particle-beam radiation therapy has many potential advantages but, thus far, safety and comparator data are still limited, and access to the technology is still confined to a few centers. Medscape Medical News |
|
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer: F1000 Ranking "Changes Clinical Practice"
Mardi 15 Septembre 2009 - 14:03 - 6 mois depuis - Cancérologie - Medscape cancérologie The EGFR mutation is now testable on a large scale and treatable with gefitinib in patients with lung cancer. Faculty of 1000 Medicine |
|
Physicians Are Talking About: The Million Med March on Washington
Mardi 15 Septembre 2009 - 09:43 - 6 mois depuis - Cancérologie - Medscape cancérologie Medscape Physician Connect members from across the country prepare to march on Washington. Medscape Family Medicine |
|
CDC’s Ambitious Goal for Colorectal Cancer Screening
Mardi 15 Septembre 2009 - 08:00 - 6 mois depuis - Cancérologie - Medscape cancérologie The Centers for Disease Control and Prevention hopes to have 80% of the population 50 years and older screened for colorectal cancer by the end of a 5-year program in many states. Medscape Medical News |
|
Combination Therapy With Transarterial Chemoembolization and Interferon-alpha Compared With Transarterial Chemoembolization Alone for Hepatitis B Virus Related Unresectable Hepatocellular Carcinoma
Lundi 14 Septembre 2009 - 15:35 - 6 mois depuis - Cancérologie - Medscape cancérologie This study examined whether IFN-alpha treatment would reduce or postpone the recurrence rate and improve the overall survival rate in patients after TACE treatment of HBV-related unresectable HCC. |
|
Lapatinib Disappoints in Liver Cancer
Lundi 14 Septembre 2009 - 14:43 - 6 mois, 1 semaine depuis - Cancérologie - Medscape cancérologie A phase 2 trial in hepatocellular carcinoma showed no objective responses, but there was a benefit in a small subgroup of patients. Medscape Medical News |
|
Promoting Prevention and Early Recognition of Malignant Melanoma
Lundi 14 Septembre 2009 - 13:35 - 6 mois, 1 semaine depuis - Cancérologie - Medscape cancérologie Learn more about the etiology, current research, and facilitators and barriers to surveillance in malignant melanoma. Dermatology Nursing |
|
Quantification of the Survival Benefit Of Early Versus Deferred Cystectomy in High-Risk Non-Muscle Invasive Bladder Cancer (T1 G3) Ranked "Changes Clinical Practice" from F1000
Lundi 14 Septembre 2009 - 12:56 - 6 mois, 1 semaine depuis - Cancérologie - Medscape cancérologie The authors review the understaging and survival of patients who underwent early versus deferred radical cystectomy for high-risk non-muscle invasive bladder cancer Faculty of 1000 Medicine |
< 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 – 21 – 22 – 23 – 24 – 25 – 26 – 27 – 28 – 29 – 30 – 31 – 32 – 33 – 43 – 53 – 63 – 73 – 83 – 93 – 103 – 113 – 123 – 133 – 143 – 153 – 163 – 173 – 183 – 193 – 203 – 213 – 223 – 233 – 243 – 253 – 263 – 273 – 283 – 293 – 303 – 313 – 323 – 333 – 343 – 353 – 363 – 373 >





Guérir parfois, soulager souvent, écouter toujours.
-- Louis Pasteur